Patients with statin intolerance should first consider evidence-based alternatives like ezetimibe, bempedoic acid, PCSK9 inhibitors, or inclisiran before considering GLP-1 therapy primarily for lipid management
79, Supplementary Table 1 and 2, and Supplementary Data 1) demonstrate that rearrangement of surrounding residues could allow BV to bind with Ab Pcob in certain conformations, where hydrophobic interactions with residues in the binding pocket (e.g., Leu252, Trp289, Leu294, Arg297, Val299 and Val303) contribute to retain BV in the correct orientation (Fig
Consult with a Provider: A licensed provider will review your information to see if a tirzepatide or semaglutide program is a safe and appropriate option for you
GLP-1 agonists function by stimulating insulin secretion, reducing blood sugar levels, and managing metabolism, which helps explain why theyre used to treat Type 2 diabetes and obesity
For most people who use it consistently alongside reasonable lifestyle habits, it produces meaningful and sustained weight loss that single-pathway GLP-1 medications often dont match
Serious but rare risks (both medications): Pancreatitis Gallbladder disease Acute kidney injury (in severe dehydration cases) Black box warning: Both carry a thyroid C-cell tumor warning based on rodent studies